Metraipolis › archive › dc_75e733f0da97

Targeting Tumour Heterogeneity through sequential timing of anti-hallmark combination therapies -a hypothesis for implementation — Europe PMC PMID:42529176

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42529176
DOI
10.3389/fimmu.2026.1882175
License (as archived)
solo-consultazione
Archived
2026-10-18T06:57:30.999Z
SHA-256 of the archived text
4595827a5a75586a40ed88da285c58f6a90f143af643b2f4f90ab1dab1bc2850
Stable URL of this page
https://metraipolis.com/documento/dc_75e733f0da97

How to cite

Targeting Tumour Heterogeneity through sequential timing of anti-hallmark combination therapies -a hypothesis for implementation — Europe PMC PMID:42529176 — Europe PMC (en), https://europepmc.org/article/MED/42529176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_75e733f0da97 (Metraipolis archive dc_75e733f0da97, sha256 4595827a5a75586a40ed88da285c58f6a90f143af643b2f4f90ab1dab1bc2850)
BibTeX
@misc{dc75e733f0da97,
  title = {Targeting Tumour Heterogeneity through sequential timing of anti-hallmark combination therapies -a hypothesis for implementation — Europe PMC PMID:42529176},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42529176},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_75e733f0da97; sha256 4595827a5a75586a40ed88da285c58f6a90f143af643b2f4f90ab1dab1bc2850},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42529176. Agents can read the archived copy with the MCP tool read_document.